A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer
NCT ID: NCT06434402
Last Updated: 2026-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2024-05-22
2026-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Harnessing Generativity Among Young Adult Cancer Survivors
NCT04272346
Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors
NCT06046014
Expressive Writing for the Management of Stress in Cancer Survivors
NCT04776941
Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors
NCT05584449
Health Benefits of Writing Therapy Among Asian American Cancer Survivors
NCT06367959
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To evaluate the feasibility of a virtual, group-based expressive writing intervention for survivors of adolescent and young adult cancer.
Secondary Objective:
To preliminarily assess the impact of the study for cancer survivors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Emerging adults (ages18-25 years)
Participants complete questionnaires over 20 minutes about their mood, health, and demographic information at baseline, and 1, and 3 months.
Participants are asked to write about their cancer experiences over 20 minutes (non-stop) for 4 weeks.
Behavioral Intervention
Write about cancer experiences
Young adults (ages 26-39 years)
Participants complete questionnaires over 20 minutes about their mood, health, and demographic information at baseline, and 1, and 3 months.
Participants are asked to write about their cancer experiences over 20 minutes (non-stop) for 4 weeks.
Behavioral Intervention
Write about cancer experiences
General group (ages 18-39 years)
Participants complete questionnaires over 20 minutes about their mood, health, and demographic information at baseline, and 1, and 3 months.
Participants are asked to write about their cancer experiences over 20 minutes (non-stop) for 4 weeks.
Behavioral Intervention
Write about cancer experiences
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Intervention
Write about cancer experiences
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 - 39 years at study entry
* Diagnosed between 1 and 5 years ago prior to enrollment
* Can speak, read, and write in English
Exclusion Criteria
* Major mental health disorder (e.g., schizophrenia or bipolar disorder \[determined from patient records or self-disclosure\])
* No internet access.
18 Years
39 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qian Lu, MD,PHD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-04531
Identifier Type: OTHER
Identifier Source: secondary_id
2024-0440
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.